istock-92036866

26 October 2018Americas

Interpol seizes 500 tonnes of illicit pharmaceuticals

More than 500 tonnes of illicit pharmaceuticals have been seized worldwide as part of a global operation led by Interpol, as announced on Tuesday.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

article

MHRA seizes fake medicine worth more than £2m

31 October 2018 The Medicines and Healthcare Products Regulatory Agency has seized more than £2 million ($2.6 million) worth of counterfeit medication in the UK, according to the a statement made by the UK government.

Counterfeiters exploiting COVID-19 outbreak: MHRA

24 March 2020 Counterfeit face masks and unauthorised antiviral medication have been seized under Interpol’s annual Operation Pangea, as criminals seek to take advantage of the COVID-19 pandemic by exploiting demand.

More on this story

Counterfeiters exploiting COVID-19 outbreak: MHRA

24 March 2020 Counterfeit face masks and unauthorised antiviral medication have been seized under Interpol’s annual Operation Pangea, as criminals seek to take advantage of the COVID-19 pandemic by exploiting demand.

article

MHRA seizes fake medicine worth more than £2m

31 October 2018 The Medicines and Healthcare Products Regulatory Agency has seized more than £2 million ($2.6 million) worth of counterfeit medication in the UK, according to the a statement made by the UK government.

More on this story

Counterfeiters exploiting COVID-19 outbreak: MHRA

24 March 2020 Counterfeit face masks and unauthorised antiviral medication have been seized under Interpol’s annual Operation Pangea, as criminals seek to take advantage of the COVID-19 pandemic by exploiting demand.

article

MHRA seizes fake medicine worth more than £2m

31 October 2018 The Medicines and Healthcare Products Regulatory Agency has seized more than £2 million ($2.6 million) worth of counterfeit medication in the UK, according to the a statement made by the UK government.

More features

Novartis shields eye-drop patent at European Patent Office

CREATES Act unfairly tips the scales to generics

LSPN launches its first-ever US awards to celebrate life sciences leaders

Pharma giants seek closure on COVID-19 vaccine rows

How Inhibrx defended a $450m damages suit

Foley & Lardner adds litigation and transaction expert in New York

UPC deals further blow to Dexcom in glucose monitor dispute with Abbott

‘A marathon and a sprint at the same time’: How we won $452m damages